148 related articles for article (PubMed ID: 7545462)
1. Beta 3 integrin-mediated fibrin clot retraction by nucleated cells: differing behavior of alpha IIb beta 3 and alpha v beta 3.
Chen YP; O'Toole TE; Leong L; Liu BQ; Diaz-Gonzalez F; Ginsberg MH
Blood; 1995 Oct; 86(7):2606-15. PubMed ID: 7545462
[TBL] [Abstract][Full Text] [Related]
2. Involvement of alpha v beta 3 integrin in mediating fibrin gel retraction.
Katagiri Y; Hiroyama T; Akamatsu N; Suzuki H; Yamazaki H; Tanoue K
J Biol Chem; 1995 Jan; 270(4):1785-90. PubMed ID: 7530248
[TBL] [Abstract][Full Text] [Related]
3. A Leu262Pro mutation in the integrin beta(3) subunit results in an alpha(IIb)-beta(3) complex that binds fibrin but not fibrinogen.
Ward CM; Kestin AS; Newman PJ
Blood; 2000 Jul; 96(1):161-9. PubMed ID: 10891446
[TBL] [Abstract][Full Text] [Related]
4. Adhesive properties of the beta 3 integrins: comparison of GP IIb-IIIa and the vitronectin receptor individually expressed in human melanoma cells.
Kieffer N; Fitzgerald LA; Wolf D; Cheresh DA; Phillips DR
J Cell Biol; 1991 Apr; 113(2):451-61. PubMed ID: 1707057
[TBL] [Abstract][Full Text] [Related]
5. A point mutation in the integrin beta 3 cytoplasmic domain (S752-->P) impairs bidirectional signaling through alpha IIb beta 3 (platelet glycoprotein IIb-IIIa).
Chen YP; O'Toole TE; Ylänne J; Rosa JP; Ginsberg MH
Blood; 1994 Sep; 84(6):1857-65. PubMed ID: 8080992
[TBL] [Abstract][Full Text] [Related]
6. Molecular mechanisms of fibrin gel clot retraction by platelets and cultured tumor cells.
Tanoue K; Katagiri Y; Suzuki H
Pol J Pharmacol; 1996; 48(3):341-3. PubMed ID: 9112674
[TBL] [Abstract][Full Text] [Related]
7. Serine 752 in the cytoplasmic domain of the beta 3 integrin subunit is not required for alpha v beta 3 postreceptor signaling events.
Kieffer N; Melchior C; Guinet JM; Michels S; Gouon V; Bron N
Cell Adhes Commun; 1996 Jul; 4(1):25-39. PubMed ID: 8870971
[TBL] [Abstract][Full Text] [Related]
8. Beta3 integrin activation improves alphavbeta3-mediated retraction of fibrin matrices.
Corbett SA; Schwarzbauer JE
J Surg Res; 1999 May; 83(1):27-31. PubMed ID: 10210638
[TBL] [Abstract][Full Text] [Related]
9. A cluster of basic amino acid residues in the gamma370-381 sequence of fibrinogen comprises a binding site for platelet integrin alpha(IIb)beta3 (glycoprotein IIb/IIIa).
Podolnikova NP; Gorkun OV; Loreth RM; Yee VC; Lord ST; Ugarova TP
Biochemistry; 2005 Dec; 44(51):16920-30. PubMed ID: 16363805
[TBL] [Abstract][Full Text] [Related]
10. Fibrin clot retraction by human platelets correlates with alpha(IIb)beta(3) integrin-dependent protein tyrosine dephosphorylation.
Osdoit S; Rosa JP
J Biol Chem; 2001 Mar; 276(9):6703-10. PubMed ID: 11084040
[TBL] [Abstract][Full Text] [Related]
11. A naturally occurring point mutation in the beta3 integrin MIDAS-like domain affects differently alphavbeta3 and alphaIIIbbeta3 receptor function.
Morel-Kopp MC; Melchior C; Chen P; Ammerlaan W; Lecompte T; Kaplan C; Kieffer N
Thromb Haemost; 2001 Dec; 86(6):1425-34. PubMed ID: 11776310
[TBL] [Abstract][Full Text] [Related]
12. A naturally occurring Tyr143His alpha IIb mutation abolishes alpha IIb beta 3 function for soluble ligands but retains its ability for mediating cell adhesion and clot retraction: comparison with other mutations causing ligand-binding defects.
Kiyoi T; Tomiyama Y; Honda S; Tadokoro S; Arai M; Kashiwagi H; Kosugi S; Kato H; Kurata Y; Matsuzawa Y
Blood; 2003 May; 101(9):3485-91. PubMed ID: 12506038
[TBL] [Abstract][Full Text] [Related]
13. Distinct functions of integrin alpha and beta subunit cytoplasmic domains in cell spreading and formation of focal adhesions.
Ylänne J; Chen Y; O'Toole TE; Loftus JC; Takada Y; Ginsberg MH
J Cell Biol; 1993 Jul; 122(1):223-33. PubMed ID: 8314843
[TBL] [Abstract][Full Text] [Related]
14. Identification of a novel binding site for platelet integrins alpha IIb beta 3 (GPIIbIIIa) and alpha 5 beta 1 in the gamma C-domain of fibrinogen.
Podolnikova NP; Yakubenko VP; Volkov GL; Plow EF; Ugarova TP
J Biol Chem; 2003 Aug; 278(34):32251-8. PubMed ID: 12799374
[TBL] [Abstract][Full Text] [Related]
15. Probing conformational changes in the I-like domain and the cysteine-rich repeat of human beta 3 integrins following disulfide bond disruption by cysteine mutations: identification of cysteine 598 involved in alphaIIbbeta3 activation.
Chen P; Melchior C; Brons NH; Schlegel N; Caen J; Kieffer N
J Biol Chem; 2001 Oct; 276(42):38628-35. PubMed ID: 11507099
[TBL] [Abstract][Full Text] [Related]
16. Requirements for alpha(5)beta(1) integrin-mediated retraction of fibronectin-fibrin matrices.
Corbett SA; Schwarzbauer JE
J Biol Chem; 1999 Jul; 274(30):20943-8. PubMed ID: 10409640
[TBL] [Abstract][Full Text] [Related]
17. Disruption of the long-range GPIIIa Cys(5)-Cys(435) disulfide bond results in the production of constitutively active GPIIb-IIIa (alpha(IIb)beta(3)) integrin complexes.
Sun QH; Liu CY; Wang R; Paddock C; Newman PJ
Blood; 2002 Sep; 100(6):2094-101. PubMed ID: 12200372
[TBL] [Abstract][Full Text] [Related]
18. 50-kD integrin-associated protein does not detectably influence several functions of glycoprotein IIb-IIIa complex in human platelets.
Fujimoto T; Fujimura K; Noda M; Takafuta T; Shimomura T; Kuramoto A
Blood; 1995 Sep; 86(6):2174-82. PubMed ID: 7662966
[TBL] [Abstract][Full Text] [Related]
19. Abciximab (ReoPro, chimeric 7E3 Fab) demonstrates equivalent affinity and functional blockade of glycoprotein IIb/IIIa and alpha(v)beta3 integrins.
Tam SH; Sassoli PM; Jordan RE; Nakada MT
Circulation; 1998 Sep; 98(11):1085-91. PubMed ID: 9736595
[TBL] [Abstract][Full Text] [Related]
20. Missense mutations in the beta(3) subunit have a different impact on the expression and function between alpha(IIb)beta(3) and alpha(v)beta(3).
Tadokoro S; Tomiyama Y; Honda S; Kashiwagi H; Kosugi S; Shiraga M; Kiyoi T; Kurata Y; Matsuzawa Y
Blood; 2002 Feb; 99(3):931-8. PubMed ID: 11806996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
